NDC 61703-161 – Methotrexate
Methotrexate Sodium 25 mg/mL · Injection, Solution · Intramuscular, Intrathecal, Intravenous, Subcutaneous
Product NDC61703-161
Product details
- Brand name
- Methotrexate
- Generic name
- Methotrexate
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intrathecal, Intravenous, Subcutaneous
- Marketing category
- NDA · NDA011719
- Marketed since
- November 4, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Active ingredients
- Methotrexate Sodium 25 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61703-161-05 | 5 VIAL, MULTI-DOSE in 1 CARTON (61703-161-05) / 2 mL in 1 VIAL, MULTI-DOSE (61703-161-02) | Nov 4, 2024 |
Other Methotrexate products
- 62332-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 62332-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 46708-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 46708-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 55150-511 Methotrexate Sodium 100 mg/4mL · Injection, Solution · Eugia US LLC
- 55150-510 Methotrexate Sodium 50 mg/2mL · Injection, Solution · Eugia US LLC
- 55150-512 Methotrexate Sodium 200 mg/8mL · Injection, Solution · Eugia US LLC
- 55150-513 Methotrexate Sodium 250 mg/10mL · Injection, Solution · Eugia US LLC
- 63323-123 Methotrexate Sodium 25 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 61703-124 Methotrexate Sodium 25 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-408 Methotrexate Sodium 25 mg/mL · Injection, Solution · Hospira, Inc.
- 61703-350 Methotrexate Sodium 25 mg/mL · Injection, Solution · Hospira, Inc.